Promoter Methylation of DNA Repair Genes Predicts Disease-free Survival of Gastric Adenocarcinoma after Adjuvant Radiotherapy

The relentless debate on postoperative adjuvant radiotherapy in gastric adenocarcinoma (GA) has been lasting for decades. In this study, a new biomarker, named promoter methylation burden of DNA repair genes (RPMB), was established to identify the subgroup of patients who might benefit from adjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Ning, Yu, Zhuang, He, Xin-Jia, Zhao, Yuan-Yuan, Yu, Li, Zhang, Yong-Chun, Lu, Hai-Jun, Yang, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334297/
https://www.ncbi.nlm.nih.gov/pubmed/32671186
http://dx.doi.org/10.1016/j.omto.2020.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334297/
https://www.ncbi.nlm.nih.gov/pubmed/32671186
http://dx.doi.org/10.1016/j.omto.2020.06.006

Ejemplares similares